TrialTrials2013

Ozurdex (a slow-release dexamethasone implant) in proliferative vitreoretinopathy: study protocol for a randomised controlled trial.

Philip J Banerjee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.